Navana Pharma Q1 Profit Up by 12%
Navana Pharmaceuticals reported a 12% year-on-year profit growth in the July-September quarter of FY2024, reaching Tk 13.37 crore. Its earnings…
Navana Pharma Q1 Profit Up by 12%
Please Subscribe to view full content
Navana Pharma Accused of Evading Tk 139 Crore VAT
A recent audit report from the Large Tax Payers Unit (LTU) of VAT revealed that Navana Pharmaceuticals Limited concealed sales…
Navana Pharma Accused of Evading Tk 139 Crore VAT
Please Subscribe to view full content
Navana Pharma to Utilize IPO Funds for Building Generic Production Unit
Please Subscribe to view full content
Navana Pharma to Utilize IPO Funds for Building Generic Production Unit
Navana Pharmaceuticals PLC, a publicly traded entity, has decided to repurpose the proceeds from its initial public offering (IPO) to…
Top 6 Pharmaceutical Firms Declares Substantial Revenue Growth
Please Subscribe to view full content
Top 6 Pharmaceutical Firms Declares Substantial Revenue Growth
During July-March, Bangladesh’s top pharmaceutical firms exhibited impressive financial results, despite economic challenges. IBN Sina Pharma led with a remarkable…
Navana Pharmaceuticals to Issue Tk 150 Crore Partial Convertible Bond
Navana Pharmaceuticals has obtained BSEC approval for issuing a partial convertible bond valued at Tk 150 crore. Priced at Tk…
Navana Pharmaceuticals to Issue Tk 150 Crore Partial Convertible Bond
Please Subscribe to view full content